In this Issue
As interest in venous therapies increases, so must careful study and dedicated training.
Chief Medical Editor’s Page
By Barry T. Katzen, MD
By Gary Siskin, MD
By Patricia K. Coyle, MD, and Jack Burks, MD
What’s available and when to use these options.
By Mark J. Garcia, MD, FSIR
Defining higher standards for vein specialists.
By Steve Elias, MD, FACS, FACPh, and Jose I. Almeida, MD, FACS, RPVI, RVT
Will continued reinvention result in a better wheel?
By Michael A. Vasquez, MD, FACS, RVT, and Cary Munschauer, BA
The importance of data collection and how you can participate in much-needed research.
By The American Venous Forum
One Question … How Have Your Protocols for IVC Filter Placement, Monitoring, and Retrieval Changed in the Past Several Years?
With H. Bob Smouse, MD; David Trost, MD; John E. Rectenwald, MD, MS; Frank R. Arko, MD; John A. Kaufman, MD, MS; Graham Plant, MBBS, FRCR; Marvin D. Atkins, MD; Mahmood K. Razavi, MD; and Raman Uberoi, BMSCPath, MBBChir, MRCP, FRCR
Current data and guidelines for choosing the best pharmacological option for each PAD patient.
By Stephen L. Chastain, MD, and Marcus D. Stanbro, DO, FSVM
A case-based look at platelet inhibitors and peripheral arterial intervention.
By Bruce H. Gray, DO, MSVM, FSCAI
A look at the black box warning, implications of generic options, the need for peripheral trials, and the potential for genetic testing.
By Karthikeshwar Kasirajan, MD
A case-based review in various vascular settings.
By Brant W. Ullery, MD; Ben M. Jackson, MD; Joseph Bavaria, MD; and Edward Y. Woo, MD
FEATURED TECHNOLOGYSponsored by Bayer HealthCare
A roundtable discussion of the challenges faced in treating deep vein thrombosis and the benefits of endovascular therapy.
By Mark J. Garcia, MD, FSIR; Robert Lookstein, MD; Mehdi H. Shishehbor, DO, MPH; and Jeffrey Wang, MD
A preview of today’s new products
Dr. Mussa shares his insights on the future of TEVAR for uncomplicated type B aortic dissection, percutaneous EVAR, and treatment options for CLI.